Lyell Immunopharma had a revenue of 7.00K in the quarter ending Mar 31, 2025, with -36.36%. This bring the company's revenue in the last twelve months to 1.26M, Increased -64.80%. In the fiscal year ending Dec 31, 2024, Lyell Immunopharma had annual revenue of 61.00K with -53.08% growth.